Related Content
- AlertNovember 21, 2024
Second Circuit Sees Eye to Eye With Warby Parker in Trademark Google Ads Dispute
- InsightJanuary 16, 2024
What’s Next for AI? Six Areas to Watch in 2024
- AlertApril 24, 2020
U.S. Supreme Court Holds Willfulness Not Needed for Recovery of Trademark Profits
- AlertJuly 9, 2015
Federal Circuit Will Not Review PTAB’s Use of the Broadest Reasonable Interpretation Claim Construction Standard in Post-Grant Proceedings
- NewsletterJanuary 23, 2015
IP Advisor
- AlertJanuary 5, 2015
Federal Circuit to Consider Whether Delay in Filing Suit Can Bar Damages or Injunctive Relief in Patent Cases
- AlertSeptember 23, 2014
The Patent Trial and Appeal Board Second Anniversary: Reflections And Strategies For The Years Ahead
- AlertJuly 11, 2014
Federal Circuit: Eastern District of Texas Should Have Stayed Litigation Pending USPTO Covered Business Method Review Proceeding
- Awards and RankingsAugust 25, 2025
Massachusetts Lawyers Weekly Names Robert Carroll a 2025 Go To Lawyer for Intellectual Property
- Awards and RankingsAugust 7, 2025
Managing IP 2025 Recognizes Goodwin and 20 Lawyers for Excellence in Intellectual Property
- WebinarJune 18, 2025 | 2:00 PM - 3:15 PM ET
ACS Webinar - Protecting the Formula: The Role of Trade Secrets in Chemical Research
- Awards and RankingsJune 5, 2025
Chambers USA 2025 Recognizes a Record Number of Goodwin Practices and Lawyers for Exceptional Client Service
- Awards and RankingsNovember 7, 2024
Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas
- Press ReleaseOctober 29, 2024
Goodwin Advises HLTH in its Acquisition by Hyve
- Press ReleaseMay 22, 2024
Human Immunology Biosciences to be Acquired by Biogen For $1.15 Billion Upfront and up to $650 Million in Potential Milestone Payments
- Awards and RankingsMarch 4, 2024
WTR 1000 2024 Names Goodwin a Leader in Trademark Law